**Core Concept:** Retrolental fibroplasia is a condition that primarily affects premature infants, characterized by fibrotic proliferation in the retina and optic nerve, leading to blindness. It is a consequence of exposure to high concentrations of oxygen therapy.

**Why the Correct Answer is Right:** Retrolental fibroplasia is primarily associated with the use of high concentrations of oxygen therapy in premature infants. This condition occurs when the oxygen levels are increased to prevent respiratory distress syndrome, leading to oxidative stress, which triggers the release of reactive oxygen species (ROS) and reactive nitrogen species (RNS). These reactive molecules cause damage to the retina and optic nerve, leading to fibrotic proliferation and blindness.

**Why Each Wrong Option is Incorrect:**

A. Hypoxia (Option A) is not the primary cause of retrolental fibroplasia. Instead, it is the result of using high oxygen concentrations to prevent respiratory distress syndrome.
B. Hypoglycemia (Option B) is unrelated to retrolental fibroplasia since it is a complication of low blood sugar levels, not associated with high oxygen therapy.
C. Hypercapnia (Option C) is a condition characterized by elevated carbon dioxide levels in the blood. It is not directly linked to retrolental fibroplasia, which is caused by high oxygen therapy.
D. Hyperoxia (Option D) refers to exposure to high levels of oxygen, similar to the correct answer. However, hyperoxia itself is not the cause of retrolental fibroplasia. It is the high concentrations of oxygen therapy that lead to oxidative stress and reactive molecules causing the fibrotic proliferation and blindness associated with retrolental fibroplasia.

**Clinical Pearl:** It is crucial for healthcare professionals to maintain a balance between preventing respiratory distress syndrome and minimizing the risk of retrolental fibroplasia in premature infants by using appropriate oxygen levels to avoid excessive oxidative stress.

**Correct Answer:** D. Hyperoxia (Option D). Hyperoxia refers to exposure to high levels of oxygen, which can lead to oxidative stress and reactive molecules causing retrolental fibroplasia when used at high concentrations in premature infants.